We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AACC and Life Diagnostics Partner to Relaunch AACC Middle East

By LabMedica International staff writers
Posted on 10 Feb 2022
Image: AACC Middle East (Photo courtesy of AACC)
Image: AACC Middle East (Photo courtesy of AACC)

The American Association for Clinical Chemistry (AACC Washington, D.C., USA) has announced a new collaboration with Life Diagnostics (Abu Dhabi, UAE) to relaunch AACC Middle East which will bring AACC's world-renowned education and scientific programs paired with a dynamic exhibit to Dubai, UAE, November 5-6, 2022.

AACC Middle East was first launched in 2018 as part of AACC's strategy to improve health outcomes globally, and it drew an overwhelmingly positive response during its initial two-year run. Like so many in-person events, it then went on hiatus after the emergence of COVID-19. However, as the pandemic has persisted and continued to challenge laboratory medicine professionals - the people on the frontlines of coronavirus testing worldwide - it has become more important than ever that AACC Middle East be resumed in order to provide lab professionals with the educational programming and networking opportunities they need at this crucial time.

AACC will work closely with Life Diagnostics in order to relaunch AACC Middle East for this purpose. The event's scientific program will feature experts from the US and the Middle East who will share gold standard, actionable information about the latest in clinical testing. Attendees will be able to come together safely and in-person with leaders in the field to share lessons learned from the pandemic to date. In addition, the exposition floor of AACC Middle East will feature the latest innovations in every area of clinical testing, including coronavirus testing, artificial intelligence (AI), mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing (NGS), point of care (POC), and automation.

"We at AACC are very excited to partner with Life Dx and other content experts in the Middle East to bring this essential conference back to the region," said AACC President Dr. Stephen R. Master. "For the past two years, laboratory medicine professionals around the world have heroically risen to the challenges we've faced during the pandemic, and I hope this meeting will fuel attendees' innovation and create new research collaborations and connections with colleagues who understand what everyone in the field has been through over these past many months."

Related Links:
AACC 
Life Diagnostics 

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more